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Autism spectrum disorders are a group of neurodevelopmental disorders characterized
by deficits in social skills and communication, stereotyped and repetitive behavior, and a
range of deficits in cognitive function. While the etiology of autism is unknown, current
research indicates that abnormalities of the cerebellum, now believed to be involved in
cognitive function and the prefrontal cortex (PFC), are associated with autism. The current
paper proposes that impaired cerebello-cortical circuitry could, at least in part, underlie
autistic symptoms. The use of animal models that allow for manipulation of genetic and
environmental influences are an effective means of elucidating both distal and proximal
etiological factors in autism and their potential impact on cerebello-cortical circuitry. Some
existing rodent models of autism, as well as some models not previously applied to the
study of the disorder, display cerebellar and behavioral abnormalities that parallel those
commonly seen in autistic patients. The novel findings produced from research utilizing
rodent models could provide a better understanding of the neurochemical and behavioral
impact of changes in cerebello-cortical circuitry in autism.
Keywords: autism, cerebellum
INTRODUCTION
AUTISM SPECTRUM DISORDERS (ASD)
Autism spectrum disorders are a group of neurodevelopmen-
tal disorders that have traditionally included autism, Asperger’s
syndrome, Rett syndrome, childhood disintegrative disorder,
and pervasive developmental disorder not otherwise specified
(American Psychiatric Association, 2000). With the impending
arrival of the DSM-V, Asperger’s syndrome, pervasive devel-
opmental disorder and childhood disintegrative disorder have
been consolidated into the overarching category of ASD, while
Rett syndrome has been removed from the diagnostic manual
(Lauritsen, 2013). Disorders within the ASD spectrum are charac-
terized by deficits in social skills and communication, stereotyped
and repetitive behavior, and a range of cognitive function deficits
that are diagnosed on average by 4.8 years of life, although
symptoms suggestive of autism have been observed as early as
6 months of age (Rogers and DiLalla, 1990; American Psychiatric
Association, 2000; Centers for Disease Control and Prevention,
2007; Ozonoff et al., 2010; Elsabbagh et al., 2012; Wolff et al.,
2012). Deficits in cognitive function most commonly observed
in ASD patients include impairments in memory and attention
as well as impairments in executive function including plan-
ning, cognitive flexibility, rule acquisition, and abstract thinking
(Ozonoff et al., 2007).
THE ETIOLOGY OF AUTISM
The etiology of autism is multifaceted. Genetic factors are known
to contribute to this disorder. According to studies investigat-
ing concordance rates in twins, the heritability of autism is
approximately 60–90% (Bailey et al., 1995; Hallmayer et al.,
2011). Studies exploring the contribution of genetics have
revealed thatmultiple genes are likely contributors to this disorder
(Muhle et al., 2004). Cytogenetic studies have found chromo-
somal abnormalities in regions such as 15q and 7q in ASD
individuals (Muhle et al., 2004; Campbell et al., 2006; Schanen,
2006; Dimitropoulos and Schultz, 2007). Variations within these
chromosomal loci are associated with an increased diagnosis of
autism (Campbell et al., 2006). Whole-genome scans implicate
chromosomes 1, 2, 4, 7, 10, 13, 15, 16, 17, 19, 22, and X (Muhle
et al., 2004). Cytogenetic studies and whole-genome searches have
yielded several candidate genes to be further researched (Muhle
et al., 2004). However, all the currently known genetic variations
contributing to autism only account for approximately 5–15% of
cases (Devlin and Scherer, 2012). It is therefore likely that genetic
factors alone are not sufficient to explain the etiology of autism.
Prenatal or perinatal environmental insults are also believed
to contribute to autism. The developing brain is particularly sus-
ceptible to environmental injury early in development (Rice and
Barone, 2000). Prenatal or neonatal exposure to certain chemi-
cals, such as ethyl alcohol, produces neuropsychological deficits
similar to autism, and several environmental causes have recently
been shown specifically to result in both autistic symptoms and an
increased likelihood of a diagnosis of autism (Landrigan, 2010).
These chemicals include thalidomide, misoprostol, and valproic
acid (VPA) (Moore et al., 2000; Rodier, 2002; Bandim et al., 2003).
However, similar to genetic explanations of autism, exposure to
known environmental agents accounts for a relatively small per-
centage of cases (Landrigan, 2010). Therefore, it is possible that
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autism results from a specific and as yet unknown combination of
genetic predisposition and environmental insults with variation
in these causes determining the severity of the phenotype.
Despite the current gap in understanding the etiology of
autism, abnormalities in neuroanatomy, behavior, and the under-
lying genetics of patients diagnosed with autism may provide
some insight into the causes of autistic symptomology. The aim
of the current review is to suggest that accumulating clinical and
preclinical research indicates that, regardless of etiology, develop-
mental pathology of the cerebellum likely plays a very important
role in autism and ASD. This hypothesis may provide a unify-
ing framework for understanding the diversity of autism research
findings as well as providing direction in the search for etiological
factors in this disease.
EVIDENCE THAT CEREBELLUM IS INVOLVED IN AUTISM
AND ASD
Although traditionally implicated in motor function, accumu-
lating evidence indicates that the cerebellum is also involved
in cognitive function (Schmahmann and Caplan, 2006). The
cerebellum is structurally and functionally abnormal in patients
diagnosed with autism or within the ASD spectrum (Fatemi
et al., 2012). Syndromes that share cognitive symptomology with
autism also frequently share genetic mutations associated with
abnormal cerebellar development.
STRUCTURAL CEREBELLAR ABNORMALITIES ARE COMMON IN
AUTISM AND ASD
Cerebellar neuropathology commonly occurs in ASD individuals.
Cerebellar hypoplasia and reduced cerebellar Purkinje cell num-
bers are the most consistent neuropathologies linked to autism
(Courchesne et al., 1988, 1994; Bauman, 1991; Courchesne, 1997;
Palmen et al., 2004; DiCicco-Bloom et al., 2006). MRI studies
report that autistic children have smaller cerebellar vermal vol-
ume as compared to typically developing children (Webb et al.,
2009). Postmortem studies report that in addition to reduced
Purkinje cell numbers, microanatomic abnormalities of the cere-
bellum in this population include excess Bergmann glia, reduc-
tions in the size and number of cells in the cerebellar nuclei, and
an active neuroinflammatory process within cerebellar white mat-
ter (Bailey et al., 1998; Bauman and Kemper, 2005; Vargas et al.,
2005).
Multiple disorders within the autism spectrum are also asso-
ciated with cerebellar abnormalities. For example, Asperger’s
syndrome has been associated with lower total cerebellar volume
and lower gray matter volume in the right cerebellum (McKelvey
et al., 1995; Hallahan et al., 2009; Yu et al., 2011). Diffusion ten-
sor magnetic resonance imaging has demonstrated that adults
with Asperger’s syndrome have reduced fractional anisotropy in
the cortico-cortical parallel fibers and Purkinje cell fibers of the
cerebellum and superior cerebellar peduncle of the right hemi-
sphere, which indicates abnormal microstructure of cerebellar
white matter. According to postmortem studies, patients with
Rett syndrome display reduced volume of the cerebellum, cere-
bellar atrophy, and reduced Purkinje cell numbers (Oldfors et al.,
1990; Murakami et al., 1992). Diffusion tensor imaging of cere-
bellar pathways in children with ASD found increased diffusivity
of the superior cerebellar peduncles, suggesting abnormal con-
nectivity between the cerebellum and the rostral-going cerebellar
projections (Sivaswamy et al., 2010).
ABNORMALITIES OF CEREBELLAR FUNCTION IN AUTISM AND ASD
ARE ASSOCIATED WITH DEFICITS IN COGNITIVE AND MOTOR
BEHAVIOR, AND SOCIAL REWARD
Imaging studies indicate that in addition to neuropathological
changes, the cerebellum is functionally abnormal in ASD patients.
Functional MRI (fMRI) work has revealed that during a visually
guided saccade task, ASD patients have increased activation of
cerebello-thalamic circuitry compared to controls (Takarae et al.,
2007). It has been reported that activation of the ipsilateral ante-
rior cerebellar hemisphere is increased in magnitude and larger in
spatial extent during simple motor tasks in ASD patients as com-
pared to control participants (Allen et al., 2004). In adults with
Asperger’s syndrome, diffusion tensor magnetic resonance imag-
ing showed that the level of severity of social impairment was
significantly negatively correlated with the degree of anisotropy
of the superior cerebellar peduncle, the primary output path
of the cerebellum. This suggests that as cerebellar white matter
decreases, symptom severity increases (Catani et al., 2008).
ASD individuals and individuals with cerebellar abnormal-
ities occurring during development or following acute injury
have similar cognitive impairments, suggesting that the cere-
bellum is directly involved in autistic symptoms. Clinical stud-
ies have shown that progressive cerebellar atrophy as well as
acute cerebellar lesions caused by tumors or infarction result in
impairments to attention, planning, set-shifting, reversal learn-
ing, verbal fluency, abstract reasoning, memory, and associa-
tive learning (Bracke-Tolkmitt et al., 1989; Botez-Marquard and
Botez, 1993; Courchesne et al., 1994; Schmahmann and Sherman,
1998; Thoma et al., 2008; Baillieux et al., 2010). In individuals
with developmental reductions in cerebellar volume, cognitive
functions such as associative learning, verbal ability, planning,
and working memory are impaired, and the degree of volume
reduction is correlated with the degree of cognitive impairment
(Steinlin, 2008; Bolduc et al., 2011, 2012).
In addition to cognitive deficits, individuals with autism
exhibit motor deficits [reviewed in Gowen and Hamilton (2013)]
which begin in infancy (Provost et al., 2007; Brian et al., 2008)
and continue through adolescence and into adulthood (Fournier
et al., 2010; Van Waelvelde et al., 2010). Motor deficits appear to
be relatively prevalent in this patient group, having been observed
in 21–100% of individuals with autism, depending on the sample
(Ghaziuddin et al., 1994; Manjiviona and Prior, 1995; Miyahara
et al., 1997; Green et al., 2002; Pan et al., 2009). Individuals with
autism exhibit both gross and fine motor deficits including slow
and repetitive hand and foot movements (Dowell et al., 2009),
slow and inaccurate manual dexterity (Green et al., 2002), unsta-
ble balance (Freitag et al., 2007), and impaired gait (Jansiewicz
et al., 2006). Interestingly, motor deficits and cognitive deficits
appear to be related in autism. Specifically, better motor skills pre-
dict better daily living skills (Jasmin et al., 2009) and deficits in
motor control predict increased severity of autistic symptoms in
adulthood (Sutera et al., 2007). The relationship between autism
and motor deficits is unsurprising considering that (1) cerebellar
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Purkinje cell loss is consistently reported in autism (Fatemi et al.,
2012) and (2) the cerebellum is able to affect regions which con-
trol cognitive and motor functions via reciprocal connections to
prefrontal cortex (PFC), posterior parietal cortex, and cortical
motor regions (Strick et al., 2009).
The mechanisms through which cerebellar deficits may affect
motor function in autism are currently unknown. Considering
that the cerebellum is an important region in the development
of internal models of action (i.e., models which predict the sen-
sory consequences of motor commands and adapt to errors), one
possibility is that motor deficits in autism result from impair-
ments in this ability. Haswell et al. (2009) observed children with
autism and age-matched controls as they learned to maneuver a
robotic arm. These authors reported that children with autism
built a stronger than normal association between self-generated
motor commands and proprioceptive feedback, suggesting that
individuals with autism process and integrate motor information
differently than controls. Interestingly, these authors also found a
strong positive relationship between the reliance on propriocep-
tion and impairments in social function, suggesting the possibility
of a relationship between cerebellar pathology and motor and
cognitive function in autism.
However, the relationship between autism and impairments in
the formation or use of internal models of action has not con-
sistently been found. Gidley Larson et al. (2008) tested children
with autism on a prism adaptation task and a reaching task to
assess their ability, relative to controls, to form internal mod-
els of action. In the prism adaptation task, children were asked
to throw balls to visual targets with and without prism goggles
which shifted the map of the visual environment. In the reaching
task, children were required to move the handle of a robotic arm
which imposed forces on the hand or displaced the cursor associ-
ated with the handle position. In both tasks, children with autism
performed indistinguishably from controls, suggesting that motor
impairments seen in autism do not result from impaired abil-
ity to form or use internal models of action. These results are
similar to those of Mostofsky et al. (2004) who found no perfor-
mance differences between children with high functioning autism
and controls on a catching task known to depend on the cerebel-
lum. Thus, although it appears that motor deficits in autism may
be related to an underlying deficit in the ability to form internal
models of action, the factors which modulate this relationship are
not yet clear.
It should also be noted that individuals diagnosed with ASD
also exhibit impairments in reward processing [reviewed in
Dichter and Adolphs (2012)]. Learning studies indicate that this
deficit appears to be specific to social as opposed to non-social
rewards. For example, Lin et al. (2012) compared performance
of individuals with and without autism on an instrumental
reward learning task in which the reward was social (pictures
of positive and negative faces) or non-social (winning or losing
money). Individuals with autism exhibited a specific behavioral
insensitivity to social rewards. In addition to learning studies,
autonomic response studies also indicate that individuals with
autism are impaired in social reward processing. For example,
Sepeta et al. (2012) examined the pupillary response in chil-
dren with and without autism and found that, in comparison
to controls, children with autism exhibited decreased pupillary
diameter when looking at happy faces. These authors interpreted
these differential findings as indicative of reduced sensitivity to
reward value of social stimuli in children with autism. Gaze ori-
entation studies in which children with autism fail to orient
to naturally occurring social stimuli also provide evidence of
impaired social reward processing in autism (Dawson et al., 1998;
Klin et al., 2009). Neuroimaging studies indicate that differences
in reward circuitry likely underlie the observed differential perfor-
mance of controls and children with autism on behavioral tasks
(Dichter et al., 2012a,b). In support of the hypothesis that the
reward impairment in autism is specific to social stimuli, Cascio
et al. (2012) found similar responses of neural reward regions to
food cues in children with autism and typically developing con-
trols. Collectively, these studies suggest that impaired social skills
in autism may result from reduced feelings of reward in response
to social stimuli.
Involvement of the cerebellum in deficits in social reward
has not been investigated in humans. It is well known, how-
ever, that disruption of afferents to the cerebellum results in
deficits in the acquisition of classical eyeblink conditioning and
causes extinction of eyeblink conditioning in well trained ani-
mals (McCormick et al., 1985; McCormick, 2005). Most recently
it has been reported that temporary, bilateral inactivation of the
cerebellar dentate nuclei reduced operant responding for a food
reward (Peterson et al., 2012). These studies are therefore con-
sistent with the idea that the cerebellum potentially may play an
important role in human reward processing.
MULTIPLE GENES NECESSARY FOR NORMAL CEREBELLAR
DEVELOPMENT ARE ASSOCIATED WITH THE SYMPTOMOLOGY OF
AUTISM
Although single genes have diverse influences on brain devel-
opment, mutations of several genes that contribute to normal
cerebellar development are consistently associated with increased
susceptibility to autism. These genes include the retinoic acid-
related orphan receptor alpha (RORα), Engrailed 2 (EN2),
Ca2+-dependent activator protein for secretion 2 (CAPS2),
and mesenchymal-epithelial transition (MET) receptor tyrosine
kinase (Campbell et al., 2006; Wang et al., 2008; Yang et al.,
2008; Sadakata and Furuichi, 2009; Nguyen et al., 2010; Sen et al.,
2010). RORα is a gene required for differentiation of cerebellar
Purkinje cells (Boukhtouche et al., 2010). The EN2 gene has been
associated with normal cerebellar development, and mutations
or deletions of EN2 result in reduced volume in the cerebellum
and foliation abnormalities (Joyner, 1996; Kuemerle et al., 2007).
CAPS2 contributes to normal cerebellar development by enhanc-
ing release of brain-derived neurotrophic factor (BDNF) and
neurotrophin-3 (NT-3) (Sato et al., 2008; Sadakata and Furuichi,
2009). The MET receptor gene has been found to contribute to
pre- and post-natal cerebellar proliferation as well as migration of
cerebrocortical cells (Powell et al., 2001, 2003; Ieraci et al., 2002).
Genetic mutations associated with increased risk for syn-
dromes associated with autistic symptomology are also associated
with abnormal cerebellar development. Patients with fragile X
syndrome, which results from a mutation of the fragile X mental
retardation 1 (FMR1) gene, exhibit cognitive symptoms similar
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to autism such as hypersensitivity to auditory, tactile, gustatory,
and olfactory stimuli, deficits in attention, mental disfunction,
and perseveration (Jin and Warren, 2000; Tsiouris and Brown,
2004). Cerebellar abnormalities such as ectopic Purkinje cells,
focal cerebellar Purkinje cell loss, and Bergmann gliosis are asso-
ciated with fragile X syndrome (Sabaratnam, 2000; Greco et al.,
2011). Mutations of the methyl CpG-binding protein 2 (MECP2)
gene are known to produce Rett syndrome, a disorder within the
autism spectrum characterized by language impairments, motor
impairments, and stereotypical behavior (Amir et al., 1999).
Patients with Rett syndrome frequently have cerebellar atrophy
that increases with age (Murakami et al., 1992).
Multiple environmental agents, including VPA, an antiepilep-
tic drug, and chlorpyrifos, an organophosphate pesticide, have
been associated with an increased risk of autism (Moore et al.,
2000; de Cock et al., 2012). Basic research also indicates that
these agents interrupt normal cerebellar development. Yochum
et al. (2008) report that rats prenatally exposed to VPA exhibit
an increased number of apoptotic cells in the cerebellum. Ingram
et al. (2000) also showed that prenatal exposure to VPA in rats
results in a decrease of Purkinje cells. Krishnan et al. (2012)
showed that in both young and adult mice, dermal exposure
to chlorpyrifos resulted in increased glial fibrillary acidic pro-
tein expression of the cerebellum, suggesting neurotoxic effects
in the cerebellums of these mice. Cole et al. (2011) reported that
repeated postnatal exposure to chlorpyrifos resulted in changes in
cerebellar gene expression. Abou-Donia et al. (2006) also reported
that rats prenatally exposed to chlorpyrifos had fewer Purkinje
cells at postnatal day 90.
It is also worth noting that an association between maternal
fever during pregnancy and the risk of ASD has recently been
reported. Zerbo et al. (2013) compared the incidence of mater-
nal fever during pregnancy in children with ASD, developmental
delay (DD), or typically developing controls. It was found that
neither ASD or DD were associated with maternal influenza, but
both conditions were associated with maternal fever during preg-
nancy. Further, the risk of ASD was reduced in mothers who
also reported taking fever reducing medications, in comparison
to mothers who did not. Although mechanisms underlying the
association between maternal fever and ASD have not been inves-
tigated, it should be remembered that the cerebellum is one brain
structure that has a very prolonged developmental time course
that extends in humans from early embryogenesis until the first
postnatal years (ten Donkelaar et al., 2003). It has been suggested
that this protracted development makes the cerebellum uniquely
vulnerable to a broad spectrum of developmental disorders (ten
Donkelaar et al., 2003). The cerebellum may also be differentially
vulnerable to fever. Preclinical research indicates that hyperther-
mic conditions induce apoptosis, disrupt neuronal maturation
and result in an enhanced activation of heat shock proteins in
the developing cerebellum (Khan and Brown, 2002; Maroni et al.,
2003; Aydin et al., 2011; Dean et al., 2012).
AUTISM DISCONNECTION HYPOTHESIS
Together, the recent findings implicating the cerebellum in autism
suggest that by genetic and/or environmental causes, neuropatho-
logical changes in the cerebellum occur in individuals with ASD.
These changes may then result in a loss or dysregulation of cere-
bellar output leading to a cascade of events which either directly
or indirectly results in the behavioral and cognitive symptoms
associated with the diagnosis of ASD. Thus, the autism discon-
nection hypothesis presented here posits that a disconnection in
the autistic brain occurs as a result of developmental cerebellar
neuropathology and particularly the loss of Purkinje cells in the
cerebellar cortex as these cells constitute the outflow of cerebellar
cortex (Palmen et al., 2004; Amaral et al., 2008; Whitney et al.,
2008).
The disconnection hypothesis asserts that the etiology of a
given disorder can be accounted for by a loss of connectivity
between two or more brain areas (Catani and Ffytche, 2008).
While this theory was originally used to explain literal severances
of circuitry, this hypothesis has more recently been expanded to
include developmental neuropathology or disturbance or dys-
regulation of neural circuitry resulting in impaired functional
connectivity (Geschwind, 1965; Geshwind and Levitt, 2007).
A disconnection occurring due to a change in cerebellar output
in ASD patients could result not only in impaired communica-
tion between the cerebellum and its efferent targets, but also in
compensations or adaptations of affiliated neuronal circuitry.
It is possible that a disconnection of cerebello-cortical pro-
jections could account for many of the cognitive symptoms
of autism. Middleton and Strick (2000) used retrograde trans-
portation of herpes simplex virus to trace multiple closed-loop,
basal ganglia- and cerebello-cortical circuits. Notably, this study
reported that the cerebellum projects, via the thalamus, to areas
46 and 9 of the PFC which is known to be involved in cogni-
tive functions such as memory, planning, and decision making
(Middleton and Strick, 2000; Schmahmann, 2001). Research also
provides a second cerebellum-PFC circuit that could influence
cognitive functions commonly attributed to the frontal cor-
tex. The cerebellum projects indirectly to the ventral tegmental
area (VTA) which contains dopamine cell bodies comprising
the mesocortical dopaminergic system that terminates in the
PFC (Fallon and Moore, 1978). Abundant evidence links PFC
dopaminergic function to a number of important cognitive abili-
ties including working memory, attentional selection, and cogni-
tive flexibility (Robbins and Roberts, 2007). Therefore, a loss of
cerebellar output could result in significant downstream effects
on either of these cerebello-PFC circuits that, in turn, could result
in deficits in higher cognitive functions that commonly occur
in ASD.
The proposed neuronal circuitry, based on these findings,
by which the cerebellum modulates PFC dopamine release is
illustrated in Figure 1. Both of these neuronal circuits originate
in cerebellar cortex Purkinje neurons that project to the deep
cerebellar nuclei including cerebellar dentate nucleus (DN). The
cerebello-ventral tegmental-cortical circuit involves indirect acti-
vation of mesocortical dopaminergic neurons via contralateral
projections of the DN to reticulo-tegmental nuclei (RTN) that,
in turn, project to pedunculopontine nuclei (PPT) and then
project to, and stimulate directly, VTA dopaminergic cell bod-
ies projecting to the medial PFC (mPFC) (Snider et al., 1976;
Perciavalle et al., 1989; Schwarz and Schmitz, 1997; Garcia-Rill
et al., 2001; Forster and Blaha, 2003; Mittleman et al., 2008;
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FIGURE 1 | Neural circuitry involved in cerebellar modulation of medial
prefrontal cortex dopamine proposed to be affected by a
developmental disconnection in autism. With the exception of inhibitory
cerebellar to dentate nucleus projections, red arrows indicate glutamatergic
pathways. The green arrow indicates the mesocortical dopaminergic
pathway. Dotted black arrow indicates feedback loop. See text for additional
details and references.
Rogers et al., 2011). The cerebello-thalamocortical circuit involves
activation of the contralateral projections of the DN to thalamic
mediodorsal/ventrolateral nuclei (ThN md/vl) that send afferents
to the mPFC to modulate mesocortical dopaminergic terminal
release in the mPFC via appositional excitatory glutamatergic
synapses (Middleton and Strick, 2001; Pinto et al., 2003; Del Arco
andMora, 2005; Mittleman et al., 2008). Considered together, this
anatomical connectivity suggests that changes in either or both
of these circuits could result in aberrant dopaminergic activity in
the mPFC.
If developmental cerebellar damage affects PFC processing, it
should be expected that abnormalities in the target structure (i.e.,
PFC), as well as at the level of the neural junctions within these
circuits (i.e., thalamus and VTA), should occur in ASD individ-
uals. As previously discussed, several cerebellar abnormalities are
affiliated with autism, but recent research also suggests that the
PFC and thalamus are abnormal in these individuals (Tsatsanis
et al., 2003; Carper and Courchesne, 2005). While abnormalities
of the VTA in ASD individuals have been infrequently investi-
gated, it has been suggested that abnormal dopamine function in
the mPFC occurs in these individuals, thus implicating a role of
this pathway in cognitive symptoms of ASD (Ernst et al., 1997).
ABNORMALITIES OF THE PFC ARE ASSOCIATED WITH AUTISM
It might be expected that as a function of loss or dysregulation
of cerebellar input to the PFC, that the PFC becomes structurally
and/or functionally abnormal in ASD patients. Studies investigat-
ing structural abnormalities of the PFC indicate that the frontal
cortex is larger in individuals with autism, and the increased vol-
ume of frontal cortex has been shown to be positively correlated
with autistic symptoms (Carper and Courchesne, 2005; Kumar
et al., 2010). Most significantly, the degree of enlargement of
the frontal cortex was directly and positively correlated with the
degree of hypoplasia in the cerebellum (Carper and Courchesne,
2000). In addition, imaging studies indicate abnormal PFC func-
tion in patients with autism. Positron emission tomography
(PET) studies demonstrate abnormal mPFC activation during
theory of mind tasks and facial expression processing in ASD
patients (Castelli et al., 2002; Wang et al., 2007; Wong et al., 2008;
Gilbert et al., 2009). Recent fMRI studies also show lower activ-
ity levels within the mPFC in individuals with autism during a
spatial working memory task (Luna et al., 2002). Furthermore,
multi-voxel pattern analyses following fMRI during attentional
tasks have shown that the spatial distribution of activation of the
mPFC differs between those with and without autism suggesting
abnormal functional organization of the mPFC in ASD patients
(Gilbert et al., 2009).
The involvement of either the cerebello-ventral tegmental-
cortical pathway or the cerebello-thalamocortical pathway in
autismwould implicate dopaminergic dysfunction, as the cerebel-
lum modulates PFC dopamine release by both of these neuronal
circuits. Although to-date this possibility has been sparsely inves-
tigated in human patients, there is a small amount of concordant
evidence. For example, systemic administration of dopamine
antagonists such as haloperidol or risperidone has been shown to
reduce aggressive behaviors, social impairments, and stereotyp-
ies in ASD patients (Cohen et al., 1980; Campbell et al., 1982;
Canitano, 2006). In contrast, administration of bromocriptine,
a dopamine agonist, has been shown to have therapeutic effects
such as a reduction in hyperactivity and attention deficits for
ASD patients (Dollfus et al., 1992). Recent biochemical analysis
of cerebrospinal fluid (CSF) levels of dopamine metabolites such
as homovanillic acid (HVA) have produced conflicting results,
with some studies reporting elevated levels in ASD patients and
others reporting no differences between patients and controls
(Lam et al., 2006). These disparate systemic drug studies and
biochemical findings may not be surprising given that centrally
administered dopamine drugs act at diverse sites throughout
the brain and CSF levels of neurotransmitter metabolites reflect
whole brain neurotransmission activity. A single PET study has
demonstrated that children with autism have reduced dopamin-
ergic activity in the mPFC (Ernst et al., 1997). While current
evidence of dopamine dysfunction in ASD patients is inconsis-
tent, relatively few studies have investigated dopamine localized to
specific brain areas. Therefore, it remains possible that dopamin-
ergic activity within certain brain areas, such as the mPFC, is
abnormal in ASD individuals.
ABNORMALITIES OF THE THALAMUS ARE ASSOCIATED WITH AUTISM
If the cerebello-thalamocortical circuit is involved in autism,
abnormalities of the thalamus should also be expected in ASD
patients. Recent MRI studies indirectly corroborate this notion
by concluding that while total brain volume is positively cor-
related with the volume of the thalamus in control brains, a
lack of correlation exists between total brain volume and vol-
ume of the thalamus in autistic brains (Tsatsanis et al., 2003;
Hardan et al., 2006; Tamura et al., 2010). The size of the tha-
lamus in ASD individuals is reduced when compared to con-
trols, and the size of the left thalamus in children with ASD is
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inversely correlated with stereotypical and repetitive behaviors
(Tamura et al., 2010; Estes et al., 2011). Mizuno et al. (2006)
also report that the temporal correlation between neurophysio-
logical events in the thalamus and the cortex in ASD individuals
exceeds that of controls, as measured by functional connectivity
MRI (fcMRI). Additionally, during a visually guided saccade task,
ASD individuals have been shown to have greater activation of
the medial thalamus as compared to controls (Takarae et al.,
2007). The thalamus has also been implicated in cognition in
non-autistic individuals as lesions to the thalamus, particularly
the mediodorsal nuclei, result in autism-like cognitive deficits
such as poor working memory, perseveration, failure to inhibit
inappropriate behaviors, and language deficits during recall and
recognition tasks (Schmahmann and Pandya, 2008; Gong et al.,
2011).
RODENTMODELS WITH CEREBELLAR ABNORMALITIES
The above-mentioned research clearly implicates the cerebellum
in autism (Courchesne et al., 1988). Similarly, the PFC and tha-
lamus have also been implicated in this disorder, which could
possibly be explained by downstream effects of cerebellar pathol-
ogy on cerebello-cortical circuitry. Abnormalities in structure and
function of all these areas have been associated with the appear-
ance or severity of autism symptoms (Carper and Courchesne,
2005; Tamura et al., 2010). The use of animal models, which allow
for manipulation of genetic and environmental influences, is an
effective means of further elucidating both distal and proximal
etiological factors and their potential impact on cerebello-cortical
circuitry. Some existing rodent models of autism, as well as some
models not previously applied to the study of this disorder, dis-
play cerebellar, behavioral, and motor abnormalities that parallel
those commonly seen in ASD patients. Genetic, viral infection,
toxic exposure, and developmental neuropathology models exist
that display the signature psychomotor impairments and cerebel-
lar pathology of autism, and are therefore useful for investigating
the behavioral impact of changes in cerebello-cortical circuitry.
The novel findings produced from research utilizing rodent mod-
els could therefore confirm and extend our understanding of the
neurochemical and behavioral impact of changes in cerebellar-
cortical circuitry.
GENETIC MODELS
As previously discussed, autism is known to be a product of mul-
tiple genetic mutations and is highly heritable. Genetic mutations
associated with autism, ASD, and similar cognitive disorders have
been replicated in rodents. As shown in Table 1, some of these
rodent models display both autism-like behavior and cerebel-
lar pathology including the FMR1 knockout (KO) mouse, the
engrailed homeobox 2 (EN2) KOmouse, and the staggerer mouse
(Goldowitz and Koch, 1986; Petit et al., 1995; Lalonde et al.,
1996; Kuemerle et al., 1997; Doulazmi et al., 2001; Rogers et al.,
2001; Ellegood et al., 2010). Similarly, the Shank3 gene has been
associated with behavioral and cerebellar abnormalities, making
Shank3 mutant mice potential candidates for investigations of
impaired cerebello-cortical circuitry (Peça et al., 2011;Wang et al.,
2011). Also included in this category is the Lurcher (Lc/+) mouse,
a mutant with a gain of function in the gene that encodes the
Grid2 locus (glutamate receptor, ionotropic, delta2) (Caddy and
Biscoe, 1979). Although the Grid2 locus has not been associated
with ASD, there is substantial overlap between the morphological
and behavioral phenotypes between these mice and patients with
these disorders.
Table 1 | Summary of genetic rodent models with cerebellar and behavioral abnormalities that parallel those observed in autism.
Rodent model Behavioral abnormalities Cerebellar abnormalities Prefrontal cortex abnormalities




Elongated spines on Purkinje cells
Decreased volume of deep cerebellar
nuclei
Hyperconnectivity of layer 5
pyramidal cells
Synapses between layer 5
pyramidal cells do not recover from
LTD as quickly as controls
EN2 KO mice Decreased play Cerebellar hypoplasia
Decreased social behaviors Decreased Purkinje cell number
Reduced aggressive behavior Foliation defects
Staggerer mutant mice Impaired spatial and reversal learning Cerebellar hypoplasia
Memory deficits Decreased Purkinje cell number
Perseverative behavior Ectopic and atrophic Purkinje cells
Abnormal responses to novel
environments
Decreased number of granule cells
Reduced volume in deep cerebellar nuclei
Shank3 mutant mice Social abnormalities
Repetitive behavior
Learning and memory deficits
Lurcher mutant mice Impaired behavioral flexibility
Repetitive behavior
Decreased Purkinje cell number Decreased mPFC dopamine release
following DN stimulation
Frontiers in Systems Neuroscience www.frontiersin.org May 2013 | Volume 7 | Article 15 | 6
Rogers et al. Autism and the cerebellum
FMR1 KNOCKOUT MICE
The FMR1 gene codes for the production of the fragile X
mental retardation protein known to be involved in cognitive
development, and mutations of this gene result in fragile X
syndrome (Verkerk et al., 1991; Goodrich-Hunsaker et al., 2011).
As discussed previously, patients with fragile X syndrome exhibit
autism-like cognitive symptoms and have an increased proba-
bility of an autism diagnosis (Rogers et al., 2001; Tsiouris and
Brown, 2004). Because of this, FMR1 KO mice have been used to
model autism. These mice display several behavioral deficits sim-
ilar to those seen in autism such as hyperactivity, perseverative
behavior, reduced spatial learning abilities, memory deficits, and
reduced fear conditioning (Bernardet and Crusio, 2006; Ey et al.,
2011; Olmos-Serrano et al., 2011). FMR1 KO mice have cerebel-
lar abnormalities such as elongated spines on cerebellar Purkinje
cells and decreased volume of cerebellar nuclei (Koekkoek et al.,
2005; Ellegood et al., 2010). Also, eye-blink conditioning, known
to be dependent on synaptic plasticity of cerebellar neurons (Kim
and Thompson, 1997), is attenuated in FMR1 KO mice suggest-
ing that these cerebellar abnormalities have functional relevance
(Koekkoek et al., 2005). Abnormalities also exist in the PFC of
FMR1 KOmice. Layer 5 pyramidal neurons display hyperconnec-
tivity in the mPFC, and synapses between these neurons are not
able to recover from long term depression as rapidly as the same
neurons in control mice (Testa-Silva et al., 2012).
EN2 KNOCKOUT MICE
The EN2 gene has been associated with autism (Petit et al., 1995;
Sen et al., 2010). EN2 is a transcription factor that regulates
gene expression necessary for normal cerebellar development.
Thus, EN2KOmice also have cerebellar abnormalities that resem-
ble those observed in autism such as hypoplasia, a reduction
in the number of Purkinje cells by approximately 40%, and
foliation defects (Millen et al., 1994; Kuemerle et al., 1997).
EN2 has also been identified as important for the development
and survival of midbrain dopaminergic neurons such as those
located in the VTA (Wallén and Perlmann, 2003; Sonnier et al.,
2007). EN2 KO mice display social impairments which parallel
symptoms of autism including decreased play, social behavior,
and aggressive behavior as compared to controls (Cheh et al.,
2006).
STAGGERER MUTANT MICE
The staggerer mouse has a mutation of the retinoic acid receptor-
related orphan receptor alpha (RORα) gene which has been
associated with autism (Hamilton et al., 1996; Nguyen et al.,
2010). This gene is responsible for Purkinje cell survival and dif-
ferentiation (Boukhtouche et al., 2006). The staggerer mouse has
cerebellar hypoplasia resulting from a perinatal loss of approx-
imately 80% of Purkinje cells with the remaining Purkinje cells
displaying defects such as reduced size and ectopic location
(Herrup and Mullen, 1979; Herrup et al., 1996; Doulazmi et al.,
2001). Other cerebellar abnormalities such as a near 100% reduc-
tion in the number of granule cells and reduced volume of the
cerebellar nuclei are also noted in these animals (Landis and
Sidman, 1978; Roffler-Tarlov and Herrup, 1981). These mice are
ataxic, which limits behavioral research, but have been found
to display behavioral deficits including impaired spatial learning
and reversal learning, memory deficits, perseverative behavior,
and abnormal responses to novel environments (Goldowitz and
Koch, 1986; Misslin et al., 1986; Lalonde et al., 1996; Lalonde and
Strazielle, 2008).
Shank3 MUTANT MICE
In humans, the Shank3 gene is found at chromosome 22q13 and
codes for a structural protein necessary for the maintenance and
plasticity of postsynaptic densities located in excitatory synapses
(Boeckers et al., 2002; Durand et al., 2007). An abnormal Shank3
mutation accounts for approximately 2% of autism cases and
has been associated with the occurrence of cognitive deficits and
disorders with similar cognitive phenotypes such as chromo-
some 22q13 deletion syndrome (Bonaglia et al., 2006; Betancur
et al., 2009; Bozdagi et al., 2010; Chen et al., 2011; Peça et al.,
2011). ASD patients with Shank3 deletions are also noted to
have severe core symptoms and mental disabilities (Chen et al.,
2011). Multiple models exist with Shank3 mutations, and sev-
eral display behaviors analogous to the core symptoms of autism
(Bozdagi et al., 2010; Bangash et al., 2011; Peça et al., 2011;
Wang et al., 2011). For example, the isoform-specific Shank3
(e4-9) homozygous mutant exhibits abnormal social behaviors,
repetitive behaviors, and learning and memory deficits (Wang
et al., 2011). Although research has not yet directly addressed
the effect of Shank3 mutations on cerebellar anatomy and func-
tion, recent research suggests that mutations of Shank3 may be
related to cerebellar abnormalities in both humans and rodents.
Shank3 has been shown to be tissue-specific with high expres-
sion in the cerebellar granule cells (Beri et al., 2007; Peça et al.,
2011). Shank3 has also been suggested to play an important role in
the recruitment of axon terminals to cerebellar granule cell den-
drites (Roussignol et al., 2005). In addition, mutations of Shank3
are associated with abnormalities or reduced synaptic expres-
sion of glutamate receptors (Bangash et al., 2011; Verpelli et al.,
2011).
LURCHER MUTANT MICE
Lurcher mutant mice have an autosomal dominant mutation
that results in nearly a complete loss of cerebellar Purkinje cells
between the 2nd and 4th weeks of life (Caddy and Biscoe, 1979;
Zuo et al., 1997). Since these mice are ataxic and display charac-
teristic lurching movements, chimeric mice, which have a vari-
able loss of Purkinje cells dependent upon the incorporation of
the wildtype lineage, have been used to examine the behavioral
impact of Purkinje cell loss (Goldowitz et al., 1992). Lurcher mice
and chimeras display impaired executive function as measured by
a serial reversal learning task (executive function), and learning
errors were negatively correlated with the number of Purkinje
cells in subsequent cell counts (Dickson et al., 2010). Belzung
et al. (2001) found that Lurcher mutant mice showed memory
deficits in a radial armmaze. Martin et al. (2010) found a negative
correlation between repetitive behaviors and cerebellar Purkinje
cell number in chimeric mice. Thus, these mice exhibit executive
dysfunction and repetitive behaviors directly related to cerebellar
Purkinje cell numbers and approximate the symptoms commonly
observed in autism.
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Recent research in Lurcher mice has also explored the
cerebello-thalamocortical and cerebello-ventral tegmental-
cortical circuits. Mittleman et al. (2008) used fixed potential
amperometry (FPA) to detect dopamine release in the mPFC fol-
lowing electrical stimulation of the cerebellar Purkinje cell layer
or DN of the cerebellum in mice. In Lurcher mice with significant
developmental cerebellar Purkinje cell loss, mPFC dopamine
release following stimulation at either site was markedly attenu-
ated in comparison to littermate mice with normal Purkinje cell
numbers.
Rogers et al. (2011) further examined these two neuronal cir-
cuits by using FPA to detect DN stimulation-evoked dopamine
release in the mPFC of mice before and after infusions of lido-
caine, a local anesthetic, or kynurenate, a broad spectrum gluta-
mate ionotropic receptor antagonist, into the VTA, mediodorsal
thalamus, or ventrolateral thalamus. Both lidocaine and kynure-
nate infusions into the VTA resulted in a comparable decrease
in dentate stimulation-evoked mPFC dopamine release (approx-
imately 50%). In a similar fashion, lidocaine or kynurenate infu-
sions into the thalamus resulted in approximately 50% decrease
in dentate stimulation-evoked dopamine release in the mPFC
suggesting that these pathways equally contribute to mPFC
dopamine modulation and that they are primarily, if not entirely,
glutamatergic. Although the Lurcher and chimera models have
no known genetic overlap with autism, these findings are impor-
tant because they demonstrate that developmental cerebellar
neuropathology in the form of Purkinje cell loss results in autistic-
like symptomatology as well as a dysregulation of dopamine
release in the mPFC.
It should be noted that FMR1 mutant mice that have an
Fmr1tm1Cgr targeted mutation and Lurcher mutants have recently
been compared by Rogers et al. in order to determine if both
mutant strains show similar changes in dopamine release in
the mPFC following electrical stimulation of the cerebellar DN
(Rogers et al., 2013). Similar to Mittleman et al. (2008) FPA was
used to monitor mPFC dopamine release evoked by DN electrical
stimulation in both mutant strains and their littermate controls.
As shown in Figure 2, in comparison to their respective littermate
controls, mutants of both strains showed markedly attenuated
dopamine release in the mPFC following brief electrical stim-
ulation of the DN, a main output nucleus of the cerebellum.
The attenuation in PFC dopamine release was accompanied by
a functional reorganization of VTA and thalamic projections.
Rogers et al. (2013) observed that in Lurcher and FMR1 wildtype
mice, cerebellar modulation of mPFC dopamine was mediated
equally by the VTA and thalamic pathways. However, in both the
Lurcher mutant and FMR1 mutants, there was a shift in modu-
latory control away from the VTA toward the thalamic pathway,
with a specific increase in modulatory strength of the dopamine
signal through the ventrolateral nucleus of the thalamus. These
results support the notion that compromised functionality of
the projections from the DN to mPFC is a consistent result
FIGURE 2 | Individual examples of medial prefrontal cortex dopamine release responses evoked by electrical stimulation (black bar, 100 pulses at
50Hz) of the dentate nucleus.
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of developmental damage to the cerebellum and provides an
explanation for the observed attenuation of mPFC dopamine
release.
VIRAL INFECTION MODELS
Children with autism display a variety of inflammatory-like
abnormalities in the brain and periphery suggesting autoimmune
system activation (Vargas et al., 2005; Careaga et al., 2010; Rose
et al., 2012). Viral infections and maternal immune activation
have therefore been suggested to play a role in the etiology of
autism (Libbey et al., 2005; Patterson, 2009, 2011). Atladóttir
et al. (2010) determined that maternal viral infection occurring
in the first trimester is associated with the diagnosis of autism.
Viral infections of developing nervous systems can alter normal
development making the risk of neuropathology following pre-
natal or neonatal exposure particularly high for areas including
the cerebellum and neocortex that continue to develop after birth
(Johnson, 1972; Sells et al., 1975). As shown in Table 2, cerebel-
lar and frontal cortex abnormalities following viral infection have
been demonstrated in two rodentmodels, the neonatal Borna dis-
ease virus (BDV) infection rat model and the maternal influenza
infection mouse model. These two animal models also display
autism-like behavioral deficits making them useful for evaluating
behavioral changes following developmental cerebellar pathology.
NEONATAL BORNA DISEASE VIRUS INFECTION RATS
BDV is a non-segmented, negative, single-strand virus that repli-
cates in neuronal nuclei of many species and produces a range
of neurological symptoms such as motor, sensory, and emo-
tional impairments (Richt et al., 1992; Eisenman et al., 1999;
Pletnikov et al., 1999). Although BDV is not considered a poten-
tial cause of autism, BDV rodent models have neuroanatomical
and behavioral abnormalities representative of the disorder. Rats
neonatally exposed to BDV display several behavioral impair-
ments including hyperactivity, impaired spatial learning, memory
deficits, decreased open-field exploration, stereotypic behavior,
and deficits in social behavior (Hornig et al., 1999; Pletnikov et al.,
1999; Rubin et al., 1999). Neonatal BDV infection in rats pro-
duces cerebellar hypoplasia and has a relatively high specificity for
Purkinje cells resulting in up to 75% loss of these cells (Bautista
et al., 1995; Eisenman et al., 1999; Hornig et al., 1999; Zocher
et al., 2000; Pletnikov et al., 2003; Williams and Lipkin, 2006).
Solbrig et al. (1996) employed high performance liquid chro-
matography (HPLC) to investigate the PFC of infected rats and
found high levels of viral nucleic acid and elevated levels of the
dopamine metabolite 3,4-dihydroxy-phenylacetic acid (DOPAC)
in the PFC suggesting a role for PFC dopamine hyperactivity in
the behavioral changes observed in this model.
MATERNAL INFLUENZA INFECTION MICE
In a sample of mothers hospitalized during pregnancy, 50% of
those whose offspring was diagnosed with autism were hospi-
talized due to influenza. Also, according to this study, the fre-
quency of autism diagnosis among children of mothers exposed
to influenza during the first trimester was approximately 6
times higher than in the general population (Atladóttir et al.,
2010). Similarly, rodents prenatally or neonatally exposed to
influenza virus display a range of behavioral deficits including
social impairments and cognitive deficits, such as impaired work-
ing memory and impaired emotional behavior (Shi et al., 2003;
Beraki et al., 2005; Asp et al., 2009). Atrophy of the cerebellum
and gene expression changes in the PFC and cerebellum have
also been observed in mice prenatally exposed to influenza virus
(Fatemi et al., 2008, 2009). Most significantly, prenatal exposure
to influenza in mice results in approximately 33% decrease in
Purkinje cell numbers, heterotopic Purkinje cells, and delayed
migration of granule cells in the cerebellum (Shi et al., 2009).
Also, Fatemi et al. (2004) observed an increase in GAD 67-kDa
protein, a rate limiting enzyme that catalyzes synthesis of GABA
from L-glutamate, in mice exposed to influenza and suggested
that this was evidence of aberrant glutamatergic activity.
TOXIC EXPOSURE MODEL
Environmental factors such as exposure to toxic chemicals dur-
ing pregnancy are also thought to contribute to autism. Thus,
some rodent models utilize prenatal or neonatal exposure to ter-
atogens known to be associated with autism. As shown in Table 3,
one such model is the prenatal valproic acid exposure rat model
which displays signature behavioral and cerebellar abnormalities
that parallel those observed in autism (Wagner et al., 2006).
PRENATAL VALPROIC ACID EXPOSURE RATS
VPA is an antiepileptic drug found to be positively correlated with
the occurrence of autism in the offspring of mothers exposed
Table 2 | Summary of viral infection rodent models with cerebellar and behavioral abnormalities that parallel those observed in autism.
Rodent model Behavioral abnormalities Cerebellar abnormalities Prefrontal cortex abnormalities
Neonatal Borna disease virus
infection rats
Hyperactivity Cerebellar hypoplasia High levels of viral nucleic acid in PFC
Elevated levels of DOPACStereotypic behavior Decreased Purkinje cell number








Gene expression changes in
cerebellum
Decreased Purkinje cell number
Heterotopic Purkinje cells
Delayed migration of granule cells
Gene expression changes in PFC
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Table 3 | Summary of toxic exposure rodent model with cerebellar and behavioral abnormalities that parallel those observed in autism.
Rodent model Behavioral abnormalities Cerebellar abnormalities Prefrontal cortex abnormalities
Prenatal valproic acid exposure
rats






Apoptotic cells in cerebellum
Decreased Purkinje cell number
Aberrant dopamine activity in PFC
to the drug during pregnancy (Arndt et al., 2005). In humans,
the behavior resulting from prenatal exposure includes delayed
speech and motor development, hyperactivity, poor social and
communication skills, and deficits in cognitive functions such as
attention (Moore et al., 2000). Likewise, mice and rats prenatally
exposed to VPA exhibit abnormal behaviors including deficits in
olfactory discrimination, decreased prepulse inhibition, hyperac-
tivity, increased stereotypy, decreased social play, and decreased
exploratory behavior, as compared to controls (Schneider and
Przewlocki, 2005; Roullet et al., 2010). Rats prenatally exposed
to VPA also exhibit cerebellar abnormalities. Yochum et al. (2008)
found that prenatal exposure to VPA in rats induced an increase in
apoptotic cells in the cerebellum, while Ingram et al. (2000) found
that rats prenatally exposed to a single VPA intra-peritoneal injec-
tion had approximately 30% fewer Purkinje cells and significantly
differed from control animals. Consistent with the disconnection
hypothesis, VPA seems to have an effect on dopamine tissue lev-
els in adult rodents following acute or chronic exposure (Löscher,
1999). Adult rats that received chronic i.p. injections of VPA had
increased dopamine tissue levels in multiple brain areas, includ-
ing frontal cortex, as measured by HPLC (Baf et al., 1994). Also,
an in vivo microdialysis study found that an acute subcutaneous
injection of VPA produced increased extracellular dopamine lev-
els in the mPFC of rats (Ichikawa and Meltzer, 1999).
SUMMARY AND CONCLUSIONS
In attempting to answer the question, “Is autism a disease of
the cerebellum,” it is apparent from clinical research that devel-
opmental damage to the cerebellum is a common occurrence
in ASD. Pre-clinical research confirms clinical observations that
there are multiple routes to developmental cerebellar damage
including genetic mutations, viral exposure, or exposure to envi-
ronmental toxins. Rodent models of autism both confirm often
reported clinical findings and also extend these findings by pro-
viding candidate pathways deserving of further research, although
both types of research are potentially limited by questions about
the selectivity of cerebellar abnormalities as opposed to the rest
of the brain. It is however intriguing to note that developmental
damage to the cerebellum is frequently associated with a diagno-
sis of ASD in humans, and in rodents cerebellar neuropathology
is associated withmany autism-like cognitive deficits. Thus, a par-
simonious answer to this initial question is, “Yes,” in many cases
it is likely that autism is associated with developmental cerebellar
damage.
Is developmental cerebellar damage the only route to the
symptoms of autism? We believe that the most likely answer to
this question is “No,” simply because the heterogeneity of symp-
toms as well as the range of symptom severity from savant skills
to profound mental and physical handicaps makes it unlikely that
there is a unitary cause for these disorders.
A third question that also should be addressed is, can glu-
tamatergic projections to the PFC be affected independently
of developmental cerebellar damage? Pre-clinical research has
demonstrated that two glutamatergic pathways from the cerebel-
lum to the PFC canmodulate dopamine release in the mPFC. This
is significant because impairments in attention, memory, and a
marked tendency to perseverate in the face of changing contin-
gencies (i.e., executive function) are well documented in patients
with ASD, and are well known to be dependent on on-going
dopaminergic activity in the mPFC (Seamans and Yang, 2004).
Research in lurcher and FMR1 mutant mice has shown that the
ability of the cerebellum to modulate mPFC dopamine release is
significantly affected by developmental cerebellar damage involv-
ing Purkinje cells, and in Lurchers, that cerebellar Purkinje cell
number is significantly correlated with autism-like deficits in
executive function, working memory and repetitive behavior.
Thus it is possible that cerebellar neuropathology which results
in changes in cerebellar output and subsequent effects on down-
stream circuitry might underlie some of the cognitive symptoms
of autism.
In terms of this question we currently believe that, depending
on the severity of developmental cerebellar neuropathology, it is
likely that glutamatergic projections to the PFC will be effected
and this will result in autistic symptomatology. This may seem
surprising given that it has been effectively argued that in a mouse
model of Rett syndrome, mutation of the MECP2 gene results
in the appearance of autism-like symptoms including increased
repetitive behaviors which can be linked to dysfunctions in GABA
signaling (Chao et al., 2010). It should be noted, however, that
paralleling the time course in the development of symptoms,
mutations involving the MECP2 locus also cause progressive
degenerative changes in the cerebellum (Murakami et al., 1992;
Reardon et al., 2010), as well as altering glutamate homeostasis
(Zhong et al., 2012).
In support of the notion that cerebellar pathology and glu-
tamatergic dysregulation co-occur, in a mouse model of frag-
ile X, neuroligin-3 KO mice were found to exhibit deficits in
social behaviors analogous to those seen in autism (Baudouin
et al., 2012). These mice showed cerebellar pathology involving
increases in the metabotropic glutamate receptor mGLUR1α
which interfered with the structure and function of circuitry in
the cerebellum. Reactivation of the production of neuroligin-3
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ameliorated behavioral deficits in these mice and reversed the
cerebellar structural deficits that were previously observed.
Our goal in the present manuscript was to provide a galvaniz-
ing theory of what may be amajor neurophysiologicalmechanism
that could account for the cognitive, motor and reward symp-
toms of autism, as well as the apparent variability in symptom
severity. Thus, acceptance of the idea that developmental dam-
age to the cerebellum is a key player in the etiology of autism
and ASDs may have explanatory power in realms other than
cognitive symptomatology. As noted previously, the diagnosis
of autism is frequently associated with co-occurring deficits in
motor function (Gowen and Hamilton, 2013). Given the rela-
tionship between cerebellar Purkinje cell loss and the occurrence
of ataxia as well as the cerebellar connections to premotor and
motor cortical regions (Strick et al., 2009; Fatemi et al., 2012) it
seems reasonable to suggest that variability in the degree of cere-
bellar damage is likely related to the severity of motor deficits in
ASD individuals.
With regard to underlying mechanisms of the social reward
impairment in autism, preclinical research links dysregulation of
meso-accumbens dopamine to deficits in social engagement and
social bond formation (Dichter et al., 2012c). As there is now
clear evidence that developmental cerebellar damage is consis-
tently associated with dysregulation of mesocortical dopamine
projections arising from the VTA in Lurcher and FMR1 mice
(Rogers et al., 2013), it is highly likely that the meso-accumbens
dopaminergic projection, also arising from the VTA, may also
show deficits in neurotransmission. As the meso-accumbens sys-
tem has been heavily implicated in reward and reinforcement
(e.g., Salamone and Correa, 2012) it is reasonable to suggest
that a putative dysfunction in meso-accumbens dopamine, that
is driven by developmental cerebellar neuropathology, could
account for the deficits in reward responsivity displayed by ASD
patients.
While it seems clear that cerebellar modulation of mPFC
dopamine release is dependent on glutamatergic pathways, there
remains a significant gap in our knowledge of the role of
dopaminergic and glutamatergic systems in autism. Several
molecular biological techniques are available for investigating
this in rodents, including the use of viral vectors to selectively
transduce, or introduce new genetic material into glutamatergic
neurons. This might provide a way to understand the behavioral
consequences and ameliorate behavioral impairments associated
with altered glutamatergic transmission within this circuitry.
Future research should also aim to determine when during the
developmental time course cerebellar lesions occur as well as
the anatomical specificity of the cerebellar deficits observed in
the reviewed rodent models. Understanding the developmental
timing and the anatomical specificity of cerebellar pathology is
important for understanding the causal mechanisms underlying
this consistent feature of autism. Additionally, given the apparent
glutamatergic dysregulation in the cerebello-ventral tegmental-
cortical pathway that occurs along with developmental cerebellar
damage we believe the scope of research should be expanded to
include investigations of other brain regions that receive effer-
ents from nuclei in this circuit, and especially the PPT. It is well
known that projections from the PPT to the substantia nigra
modulate dopamine transmission in the dorsal striatum (Forster
and Blaha, 2003). Thus, it would be expected that developmental
cerebellar damage is also associated with dysregulation in striatal
dopamine transmission. Ultimately, a better understanding of the
direct effects of cerebellar pathology in autism could lead to better
diagnosticmeasures, earlier diagnosis, and novel pharmacological
targets for the treatment of autism and ASD.
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